ALXN1720 clinical trials

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

This study is looking into a new medicine, ALXN1720, for adults with generalised myasthenia gravis (gMG). We want to see if it's safe and helps improve symptoms for people whose gMG is caused by certain antibodies. It's compared against a dummy treatment.